Target intelligence / Profile preview

POU class 3 homeobox 4 (POU3F4)

Target
POU3F4
Molecular classification
Transcription factor
01

Overview

POU class 3 homeobox 4 (POU3F4) is a neural transcription factor encoded by a gene on the X chromosome, primarily involved in early neural development and the formation of the middle and inner ear structures[1][2][4]. It is a member of the POU domain family of transcription factors, characterized by distinct DNA-binding domains and primarily active during embryonic development, where it helps regulate gene expression patterns governing neural and ear formation[1][2][4]. Mutations in POU3F4 cause X-linked nonsyndromic hearing loss (DFN3/DFNX2), often presenting as mixed hearing loss with inner and middle ear abnormalities; affected males are at high risk for surgical complications such as perilymphatic gusher during ear surgery[2]. No approved drugs directly target POU3F4, as it is not a classic therapeutic target but a developmental transcription factor whose dysfunction leads to genetic disease.

Other names
BRAIN-4brain-specific homeobox/POU domain protein 4Brn-4BRN4DFN3DFNX2OTF9PO34_HUMANOct-9Octamer-binding protein 9Octamer-binding transcription factor 9
02

Biological functions

Regulation of gene expressionNeural developmentInner ear development
03

Disease associations

Nonsyndromic hearing loss (X-linked, DFN3/DFNX2)Inner and middle ear malformations
04

Safety considerations

Surgical risk of perilymphatic gusher (severe fluid leak from inner ear) in affected males undergoing stapes surgery due to POU3F4 mutations
05

Biomarkers

POU3F4 mutation status as a genetic biomarker for X-linked nonsyndromic hearing loss

Beyond the preview

Go deeper on POU class 3 homeobox 4 (POU3F4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on POU class 3 homeobox 4 (POU3F4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call